Hady Lichaa
Latest contributions
Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock
03 Jul 2023
This is the largest real world observational data that confirms the safety and efficacy of TAVR for the treatment of patients with severe aortic stenosis presenting with cardiogenic shock.
Reviewer
Reviewer
Clinical Cases on Peripheral Interventions - Part 1
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of cases on peripheral interventions: peripheral angioplasty for gangrenous left ring finger with septicaemia, dangerous leaks in thoracic aortic aneurysm secondary to ataphylococcus aureus, and much more!
Innovative devices for innovative procedures
17 May 2022 – From EuroPCR 2022
This session focuses on innovations to invent or improve therapeutic modalities in the cath lab based on unmet needs in PCI, LAAO, CHF interventions, intravascular imaging and therapeutics, TAVI, and peripheral vascular interventions.
PCR's Got Talent - Coronary and Other Cardiovascular Interventions
18 May 2021 – From EuroPCR 2021
Thanks to the abstracts gathered in this session, analyze the impact of repeat revascularization on 10-year mortality, study the randomized comparison between radial and femoral large-bore access in complex PCI, appraise the value of absolute flow measurement in patients with CAD, and much more!
EuroPCR 2021 - Innovations in tricuspid / pulmonary valve
18 May 2021 – From EuroPCR 2021
Watch this session to discover how ovine, sheep, or ram models can be used when discussing valve replacement, to measure the need for TCR solutions for the treatment of TR, and to consider basilic vein access for small-bore pulmonary embolism interventions.
Unusual complications after peripheral interventions
28 Apr 2021 – From EuroPCR 2021
Here is the session you need to watch to know how to find an extreme alternative arterial access in critical limb ischemia, to appreciate an X-ray finding with percutaneous solution, to learn how to cover an iatrogenic radial fistula, and even more!
